anapn1
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 25, 2023 (NCT05905432)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Anopheles gambiaeImmunity, active
immunity, active - Anopheles gambiae
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05905432 | Phase 1 | Jul 25, 2023 | Centre de Recherche Médicale de Lambaréné, Global Health Innovative Technology Fund, University of Florida |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centre de Recherche Médicale de Lambaréné | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Global Health Innovative Technology Fund | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Florida | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1